{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:27:18Z","timestamp":1779251238810,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C24E\/19\/070"],"award-info":[{"award-number":["C24E\/19\/070"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["AKUL15-30\/G0H1216N"],"award-info":[{"award-number":["AKUL15-30\/G0H1216N"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0A6222N"],"award-info":[{"award-number":["G0A6222N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["I000321N"],"award-info":[{"award-number":["I000321N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1226524 N-7029"],"award-info":[{"award-number":["1226524 N-7029"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"DOI":"10.1186\/s41181-025-00331-0","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:10:03Z","timestamp":1740143403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development and evaluation of Hsp90-targeting nanobodies for visualisation of extracellular Hsp90 in tumours using PET imaging"],"prefix":"10.1186","volume":"10","author":[{"given":"Valeria","family":"Narykina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janke","family":"Kleynhans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Cawthorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Schymkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0335-7190","authenticated-orcid":false,"given":"Guy","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"331_CR1","unstructured":"Apiyo D. Biomolecular Binding Kinetics Assays on the Octet\u00ae BLI Platform [Internet]. Fremont, CA; 2022 Dec. Available from: www.sartorius.com"},{"issue":"9","key":"331_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.chembiol.2013.08.004","volume":"20","author":"JJ Barrott","year":"2013","unstructured":"Barrott JJ, Hughes PF, Osada T, Yang X-Y, Hartman ZC, Loiselle DR, et al. Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells. Chem Biol. 2013a;20(9):1187\u201397.","journal-title":"Chem Biol"},{"issue":"9","key":"331_CR3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.chembiol.2013.08.004","volume":"20","author":"JJ Barrott","year":"2013","unstructured":"Barrott JJ, Hughes PF, Osada T, Yang X-Y, Hartman ZC, Loiselle DR, et al. Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells. Chem Biol. 2013b;20(9):1187\u201397.","journal-title":"Chem Biol"},{"issue":"1","key":"331_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.0906-6705.2004.00114.x","volume":"13","author":"B Becker","year":"2004","unstructured":"Becker B, Multhoff G, Farkas B, Wild P-J, Landthaler M, Stolz W, et al. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol. 2004a;13(1):27\u201332. https:\/\/doi.org\/10.1111\/j.0906-6705.2004.00114.x.","journal-title":"Exp Dermatol"},{"issue":"1","key":"331_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.0906-6705.2004.00114.x","volume":"13","author":"B Becker","year":"2004","unstructured":"Becker B, Multhoff G, Farkas B, Wild P-J, Landthaler M, Stolz W, et al. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol. 2004b;13(1):27\u201332. https:\/\/doi.org\/10.1111\/j.0906-6705.2004.00114.x.","journal-title":"Exp Dermatol"},{"issue":"2","key":"331_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0014-4827(88)90460-0","volume":"177","author":"GAM Berbers","year":"1988","unstructured":"Berbers GAM, Kunnen R, van Bergen en Henegouwen PMP, vanWijk R. Localization and quantitation of hsp84 in mammalian cells. Exp Cell Res. 1988;177(2):257\u201371.","journal-title":"Exp Cell Res"},{"key":"331_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33916-3","author":"K Bhattacharya","year":"2022","unstructured":"Bhattacharya K, Maiti S, Zahoran S, Weidenauer L, Hany D, Wider D, Bernasconi L, Quadroni M, Collart M, Picard D. Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-33916-3.","journal-title":"Nat Commun"},{"key":"331_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-3-030-23158-3_13","volume-title":"Heat Shock Protein 90 in Human Diseases and Disorders","author":"C Chen","year":"2019","unstructured":"Chen C, Jeffery C. Moonlighting Functions of Heat Shock Protein 90. In: Asea AAA, Kaur P, editors. Heat Shock Protein 90 in Human Diseases and Disorders. Cham: Springer International Publishing; 2019. p. 269\u201379. https:\/\/doi.org\/10.1007\/978-3-030-23158-3_13."},{"key":"331_CR9","doi-asserted-by":"publisher","first-page":"108418","DOI":"10.1016\/j.nucmedbio.2023.108418","volume":"126-127","author":"R Cools","year":"2023","unstructured":"Cools R, Narykina V, Vermeulen K, Bormans G. [11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics. Nucl Med Biol. 2023a;126\u2013127:108418. https:\/\/doi.org\/10.1016\/j.nucmedbio.2023.108418.","journal-title":"Nucl Med Biol"},{"key":"331_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-023-00189-0","author":"R Cools","year":"2023","unstructured":"Cools R, Vermeulen K, Narykina V, Leitao RCF, Bormans G. Radiosynthesis and preclinical evaluation of [11C]SNX-ab as an Hsp90\u03b1,\u03b2 isoform-selective PET probe for in vivo brain and tumour imaging. EJNMMI Radiopharm Chem. 2023b. https:\/\/doi.org\/10.1186\/s41181-023-00189-0.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"4","key":"331_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1021\/acschembio.7b00006","volume":"12","author":"LB Crowe","year":"2017","unstructured":"Crowe LB, Hughes PF, Alcorta DA, Osada T, Smith AP, Totzke J, Loiselle DR, Lutz ID, Gargesha M, Roy D, Roques J, David Darr H, Lyerly K, Spector NL, Haystead TAJ. A fluorescent Hsp90 probe demonstrates the unique association between extracellular Hsp90 and malignancy in Vivo. ACS Chem Biol. 2017;12(4):1047\u201355. https:\/\/doi.org\/10.1021\/acschembio.7b00006.","journal-title":"ACS Chem Biol"},{"key":"331_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1608-z","author":"CV Devarakonda","year":"2015","unstructured":"Devarakonda CV, Kita D, Phoenix KN, Claffey KP. Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors. BMC Cancer. 2015. https:\/\/doi.org\/10.1186\/s12885-015-1608-z.","journal-title":"BMC Cancer"},{"issue":"10","key":"331_CR13","doi-asserted-by":"publisher","first-page":"e26044","DOI":"10.1371\/journal.pone.0026044","volume":"6","author":"PC Echeverr\u00eda","year":"2011","unstructured":"Echeverr\u00eda PC, Bernthaler A, Dupuis P, Mayer B, Picard D. An interaction network predicted from public data as a discovery tool: application to the Hsp90 molecular chaperone machine. PLoS ONE. 2011;6(10):e26044. https:\/\/doi.org\/10.1371\/journal.pone.0026044.","journal-title":"PLoS ONE"},{"issue":"2","key":"331_CR14","doi-asserted-by":"publisher","first-page":"e0191109","DOI":"10.1371\/journal.pone.0191109","volume":"13","author":"T Eguchi","year":"2018","unstructured":"Eguchi T, Sogawa C, Okusha Y, Uchibe K, Iinuma R, Ono K, Nakano K, Murakami J, Itoh M, Arai K, Fujiwara T, Namba Y, Murata Y, Ohyama K, Shimomura M, Okamura H, Takigawa M, Nakatsura T, Kozaki K-I, Okamoto K, Calderwood SK. Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment. PLoS ONE. 2018;13(2):e0191109. https:\/\/doi.org\/10.1371\/journal.pone.0191109.","journal-title":"PLoS ONE"},{"issue":"5","key":"331_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12192-013-0413-3","volume":"18","author":"A Finka","year":"2013","unstructured":"Finka A, Goloubinoff P. Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis. Cell Stress Chaperon. 2013;18(5):591\u2013605. https:\/\/doi.org\/10.1007\/s12192-013-0413-3.","journal-title":"Cell Stress Chaperon"},{"issue":"3","key":"331_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12192-008-0035-3","volume":"13","author":"P Flandrin","year":"2008","unstructured":"Flandrin P, Guyotat D, Duval A, Cornillon J, Tavernier E, Nadal N, Campos L. Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells. Cell Stress Chaper. 2008;13(3):357\u201364. https:\/\/doi.org\/10.1007\/s12192-008-0035-3.","journal-title":"Cell Stress Chaper"},{"issue":"3","key":"331_CR17","doi-asserted-by":"publisher","first-page":"e0121673","DOI":"10.1371\/journal.pone.0121673","volume":"10","author":"B Forsstr\u00f6m","year":"2015","unstructured":"Forsstr\u00f6m B, Axn\u00e4s BB, Rockberg J, Danielsson H, Bohlin A, Uhlen M. Dissecting Antibodies with Regards to Linear and Conformational Epitopes. PLoS ONE. 2015;10(3):e0121673. https:\/\/doi.org\/10.1371\/journal.pone.0121673.","journal-title":"PLoS ONE"},{"key":"331_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The Proteomics Protocols Handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. Protein Identification and Analysis Tools on the ExPASy Server. In: Walker JM, editor. The Proteomics Protocols Handbook. Totowa, NJ: Humana Press; 2005. p. 571\u2013607. https:\/\/doi.org\/10.1385\/1-59259-890-0:571."},{"issue":"3","key":"331_CR19","doi-asserted-by":"publisher","first-page":"e17649","DOI":"10.1371\/journal.pone.0017649","volume":"6","author":"U Gopal","year":"2011","unstructured":"Gopal U, Bohonowych JE, Lema-Tome C, Liu A, Garrett-Mayer E, Wang B, Isaacs JS. A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion. PLoS ONE. 2011;6(3):e17649. https:\/\/doi.org\/10.1371\/journal.pone.0017649.","journal-title":"PLoS ONE"},{"issue":"5","key":"331_CR20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"45","key":"331_CR21","doi-asserted-by":"publisher","first-page":"37732","DOI":"10.1074\/jbc.M112.389015","volume":"287","author":"MW Hance","year":"2012","unstructured":"Hance MW, Dole K, Gopal U, Bohonowych JE, Jezierska-Drutel A, Neumann CA, Liu H, Garraway IP, Isaacs JS. Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer. J Biol Chem. 2012;287(45):37732\u201344. https:\/\/doi.org\/10.1074\/jbc.M112.389015.","journal-title":"J Biol Chem"},{"issue":"8","key":"331_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nchem.2811","volume":"9","author":"HD Herce","year":"2017","unstructured":"Herce HD, Schumacher D, Schneider AFL, Ludwig AK, Mann FA, Fillies M, Kasper M-A, Reinke S, Krause E, Heinrich Leonhardt M, Cardoso C, Hackenberger CPR. Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells. Nat Chem. 2017;9(8):762\u201371. https:\/\/doi.org\/10.1038\/nchem.2811.","journal-title":"Nat Chem"},{"key":"331_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0956-7","author":"K Kaneko","year":"2020","unstructured":"Kaneko K, Osada T, Morse MA, Gwin WR, Ginzel JD, Snyder JC, Yang X-Y, Liu C-X, Diniz MA, Bodoor K, Hughes PF, Haystead TAJ, Kim Lyerly H. Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors. Commun Biol. 2020. https:\/\/doi.org\/10.1038\/s42003-020-0956-7.","journal-title":"Commun Biol"},{"issue":"1","key":"331_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2967\/jnumed.115.162024","volume":"57","author":"M Keyaerts","year":"2016","unstructured":"Keyaerts M, Xavier C, Heemskerk J, Devoogdt N, Everaert H, Ackaert C, Vanhoeij M, Duhoux FP, Gevaert T, Simon P, Schallier D, Fontaine C, Vaneycken I, Vanhove C, De Greve J, Lamote J, Caveliers V, Lahoutte T. Phase I Study of68 Ga-HER2-Nanobody for PET\/CT assessment of HER2 expression in breast carcinoma. J Nucl Med. 2016;57(1):27\u201333. https:\/\/doi.org\/10.2967\/jnumed.115.162024.","journal-title":"J Nucl Med"},{"issue":"6","key":"331_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s12192-010-0211-0","volume":"15","author":"H Kubota","year":"2010","unstructured":"Kubota H, Yamamoto S, Itoh E, Abe Y, Nakamura A, Izumi Y, Okada H, Iida M, Nanjo H, Itoh H, Yamamoto Y. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperon. 2010;15(6):1003\u201311. https:\/\/doi.org\/10.1007\/s12192-010-0211-0.","journal-title":"Cell Stress Chaperon"},{"issue":"9","key":"331_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.annonc.2022.05.518","volume":"33","author":"Y Kurokawa","year":"2022","unstructured":"Kurokawa Y, Honma Y, Sawaki A, Naito Y, Iwagami S, Komatsu Y, Takahashi T, Nishida T, Doi T. Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase\u00a0III trial. Ann Oncol. 2022;33(9):959\u201367. https:\/\/doi.org\/10.1016\/j.annonc.2022.05.518.","journal-title":"Ann Oncol"},{"issue":"1","key":"331_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3892\/or.2022.8443","volume":"49","author":"Z-N Li","year":"2022","unstructured":"Li Z-N, Luo Y. HSP90 inhibitors and cancer: prospects for use in targeted therapies (Review). Oncol Rep. 2022;49(1):6. https:\/\/doi.org\/10.3892\/or.2022.8443.","journal-title":"Oncol Rep"},{"issue":"3","key":"331_CR28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbamcr.2011.09.009","volume":"1823","author":"W Li","year":"2012","unstructured":"Li W, Sahu D, Tsen F. Secreted heat shock protein-90 (Hsp90) in wound healing and cancer. Biochim Et Biophys Acta (BBA)\u2014Mol Cell Res. 2012;1823(3):730\u201341. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.09.009.","journal-title":"Biochim Et Biophys Acta (BBA)\u2014Mol Cell Res"},{"issue":"3","key":"331_CR29","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms23031328","volume":"23","author":"O Morana","year":"2022","unstructured":"Morana O, Wood W, Gregory CD. The Apoptosis Paradox in Cancer. Int J Mol Sci. 2022;23(3):1328. https:\/\/doi.org\/10.3390\/ijms23031328.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"331_CR30","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1002\/jcb.27039","volume":"119","author":"K Ono","year":"2018","unstructured":"Ono K, Eguchi T, Sogawa C, Calderwood SK, Futagawa J, Kasai T, Seno M, Okamoto K, Sasaki A, Kozaki K-I. HSP\u2010enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. J Cell Biochem. 2018;119(9):7350\u201362. https:\/\/doi.org\/10.1002\/jcb.27039.","journal-title":"J Cell Biochem"},{"issue":"24","key":"331_CR31","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1158\/1078-0432.CCR-17-1453","volume":"23","author":"T Osada","year":"2017","unstructured":"Osada T, Kaneko K, Gwin WR, Morse MA, Hobeika A, Pogue BW, et al. In vivo detection of hsp90 identifies breast cancers with aggressive behavior. Clin Cancer Res. 2017;23(24):7531\u201342.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"331_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1158\/1535-7163.MCT-21-0334","volume":"21","author":"T Osada","year":"2022","unstructured":"Osada T, Crosby EJ, Kaneko K, Snyder JC, Ginzel JD, Acharya CR, Yang X-Y, Polascik TJ, Spasojevic I, Nelson RC, Hobeika A, Hartman ZC, Neckers LM, Rogatko A, Hughes PF, Huang J, Morse MA, Timothy Haystead H, Lyerly K. HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study. Mol Cancer Ther. 2022;21(1):217\u201326. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0334.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"331_CR33","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1021\/ja110226y","volume":"133","author":"D Park","year":"2011","unstructured":"Park D, Don AS, Massamiri T, Karwa A, Warner B, MacDonald J, et al. Noninvasive Imaging of Cell Death Using an Hsp90 Ligand. J Am Chem Soc. 2011;133(9):2832\u20135. https:\/\/doi.org\/10.1021\/ja110226y.","journal-title":"J Am Chem Soc"},{"issue":"7","key":"331_CR34","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1158\/0008-5472.CAN-06-4511","volume":"67","author":"E Pick","year":"2007","unstructured":"Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, et al. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res. 2007;67(7):2932\u20137.","journal-title":"Cancer Res"},{"key":"331_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9053274","author":"X Quan","year":"2020","unstructured":"Quan X, Kwak BS, Lee J-Y, Park JH, Lee A, Kim TH, Park S. Cordyceps militaris Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer. Evid-Based Complement Altern Med. 2020. https:\/\/doi.org\/10.1155\/2020\/9053274.","journal-title":"Evid-Based Complement Altern Med"},{"issue":"4","key":"331_CR36","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1091\/mbc.e11-06-0575","volume":"23","author":"D Sahu","year":"2012","unstructured":"Sahu D, Zhao Z, Tsen F, Cheng C-F, Park R, Situ AJ, Dai J, Eginli A, Shams S, Chen M, Ulmer TS, Conti P, Woodley DT, Li W. A potentially common peptide target in secreted heat shock protein-90\u03b1 for hypoxia-inducible factor-1\u03b1\u2013positive tumors. Mol Biol Cell. 2012;23(4):602\u201313. https:\/\/doi.org\/10.1091\/mbc.e11-06-0575.","journal-title":"Mol Biol Cell"},{"key":"331_CR37","unstructured":"Salim N, Yadav A, Liao-Chan S, Theunissen J-W. High-Throughput Assays for Epitope Binning and Cross-Competition Analysis in Antibody Research [Internet]. Fremont, CA; 2024 May. Available from: www.sartorius.com"},{"issue":"16","key":"331_CR38","doi-asserted-by":"publisher","first-page":"14247","DOI":"10.18632\/oncotarget.3679","volume":"6","author":"H Shao","year":"2015","unstructured":"Shao H, Zhang J, Sun Z, Chen F, Dai X, Li Y, et al. Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models. Oncotarget. 2015;6(16):14247\u201359. https:\/\/doi.org\/10.18632\/oncotarget.3679.","journal-title":"Oncotarget"},{"key":"331_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-0590-x","author":"IH Shon","year":"2020","unstructured":"Shon IH, Kumar D, Sathiakumar C, Berghofer P, Van K, Chicco A, Hogg PJ. Biodistribution and imaging of an hsp90 ligand labelled with 111In and 67Ga for imaging of cell death. EJNMMI Res. 2020. https:\/\/doi.org\/10.1186\/s13550-020-0590-x.","journal-title":"EJNMMI Res"},{"issue":"3","key":"331_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/1874471014666211122100646","volume":"15","author":"IH Shon","year":"2022","unstructured":"Shon IH, Kumar D, Schreuder M, Guille J, Doan J, Sathikumar C, et al. Preclinical Assessment of [68Ga]Ga-Cell Death Indicator (CDI): A Novel hsp90 Ligand for Positron Emission Tomography of Cell Death. Curr Radiopharm. 2022;15(3):184\u201393.","journal-title":"Curr Radiopharm"},{"issue":"9","key":"331_CR41","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00259-023-06266-5","volume":"50","author":"W Song","year":"2023","unstructured":"Song W, Wei W, Lan X, Cai W. Albumin binding improves nanobody pharmacokinetics for dual-modality PET\/NIRF imaging of CEACAM5 in colorectal cancer models. Eur J Nucl Med Mol Imaging. 2023;50(9):2591\u20134. https:\/\/doi.org\/10.1007\/s00259-023-06266-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"331_CR42","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1158\/1078-0432.CCR-06-1585","volume":"13","author":"D Stellas","year":"2007","unstructured":"Stellas D, Karameris A, Patsavoudi E. Monoclonal Antibody 4C5 Immunostains Human Melanomas and Inhibits Melanoma Cell Invasion and Metastasis. Clin Cancer Res. 2007;13(6):1831\u20138.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"331_CR43","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1038\/sj.onc.1210897","volume":"27","author":"S Tsutsumi","year":"2008","unstructured":"Tsutsumi S, Scroggins B, Koga F, Lee M-J, Trepel J, Felts S, et al. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene. 2008;27(17):2478\u201387.","journal-title":"Oncogene"},{"issue":"6","key":"331_CR44","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2967\/jnumed.115.171306","volume":"57","author":"G Vaidyanathan","year":"2016","unstructured":"Vaidyanathan G, McDougald D, Choi J, Koumarianou E, Weitzel D, Osada T, et al. Preclinical Evaluation of 18 F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET. J Nucl Med. 2016;57(6):967\u201373. https:\/\/doi.org\/10.2967\/jnumed.115.171306.","journal-title":"J Nucl Med"},{"issue":"2","key":"331_CR45","doi-asserted-by":"publisher","first-page":"554","DOI":"10.7150\/thno.27213","volume":"9","author":"K Vermeulen","year":"2019","unstructured":"Vermeulen K, Naus E, Ahamed M, Attili B, Siemons M, Luyten K, et al. Evaluation of [11 C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90. Theranostics. 2019;9(2):554\u201372.","journal-title":"Theranostics"},{"issue":"6","key":"331_CR46","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.7150\/jca.69710","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang J, Han Z, Ma L, Li Y. 18 F-labeled dimer-sansalvamide a cyclodecapeptide: a novel diagnostic probe to discriminate pancreatic cancer from inflammation in a nude mice model. J Cancer. 2022;13(6):1848\u201358.","journal-title":"J Cancer"},{"issue":"10","key":"331_CR47","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc1716","volume":"5","author":"L Whitesell","year":"2005","unstructured":"Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer. 2005;5(10):761\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"331_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.nucmedbio.2016.01.002","volume":"43","author":"C Xavier","year":"2016","unstructured":"Xavier C, Blykers A, Vaneycken I, D\u2019Huyvetter M, Heemskerk J, Lahoutte T, et al. 18F-nanobody for PET imaging of HER2 overexpressing tumors. Nucl Med Biol. 2016;43(4):247\u201352.","journal-title":"Nucl Med Biol"},{"key":"331_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.963719\/full","author":"Z Yuan","year":"2022","unstructured":"Yuan Z, Wang L, Chen C. Analysis of the prognostic, diagnostic and immunological role of HSP90\u03b1 in malignant tumors. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.963719\/full.","journal-title":"Front Oncol"},{"issue":"10","key":"331_CR50","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1021\/acs.jmedchem.0c00305","volume":"63","author":"S Zhu","year":"2020","unstructured":"Zhu S, Shen Q, Gao Y, Wang L, Fang Y, Chen Y, et al. Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor\u2013SN38 Conjugates for Targeted Drug Accumulation. J Med Chem. 2020;63(10):5421\u201341. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00305.","journal-title":"J Med Chem"},{"issue":"15","key":"331_CR51","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/onc.2016.375","volume":"36","author":"M Zou","year":"2017","unstructured":"Zou M, Bhatia A, Dong H, Jayaprakash P, Guo J, Sahu D, et al. Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression. Oncogene. 2017;36(15):2160\u201371.","journal-title":"Oncogene"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-025-00331-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-025-00331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:10:09Z","timestamp":1740143409000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmipharmchem.springeropen.com\/articles\/10.1186\/s41181-025-00331-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1186\/s41181-025-00331-0","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}